Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
999.00
-28.00 (-2.73%)
Nov 20, 2026, 3:30 PM KST
KRX:002210 Market Cap
KRX:002210 has a market cap or net worth of 93.79 billion as of November 20, 2026. It is the 27,116th most valuable company in the world and the 1,232nd biggest in South Korea. Its market cap has increased by 303.58% in one year.
Market Cap
93.79B
Enterprise Value
n/a
Revenue
78.44B
Global Rank
Country Rank
#1,232 South Korea
PE Ratio
10.37
ChartMarket Cap Chart
Since August 31, 1995, KRX:002210's market cap has increased from 22.58B to 93.79B, an increase of 315.41%. That is a compound annual growth rate of 4.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 93.79B | -11.41% |
| Dec 30, 2024 | 105.87B | -19.62% |
| Dec 28, 2023 | 131.71B | -13.77% |
| Dec 29, 2022 | 152.74B | -22.87% |
| Dec 30, 2021 | 198.03B | -32.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yungjin Pharm. | 141.19B |
| Ilsung Is | 140.77B |
| Dongwha Pharm.Co.,Ltd | 134.29B |
| Jeil Pharmaceutical Co.,Ltd | 121.17B |
| Kyongbo Pharmaceutical | 115.95B |
| SAMSUNG PHARM. Co., LTD. | 114.92B |
| AptaBio Therapeutics | 114.06B |
| Ilyang Pharmaceutical Co.,Ltd | 111.13B |